DrugDashboards

Sodium Chloride

Sodium Chloride · SODIUM CHLORIDE 900 mg/100mL · Injection, Solution · Intravenous · Hospira, Inc.

NDC 00409-7101-02 · 24 POUCH in 1 CASE / 1 BAG in 1 POUCH / 250 mL in 1 BAG · NDA · View full market →

The short version

20 companies supply this market — deep enough that no single failure threatens the supply. Put together: worth watching — several of the pressures that precede supply trouble are present at once. Historically, drugs in this position went on to a new shortage within 90 days about 1.5% of the time — roughly 10× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.0210per MLinvoice-surveyed acquisition cost · Aug 20, 2025
  • Medicare Part B pays (ASP+6%)$2.18per billing unit (1000 CC)HCPCS J7030 · Jul 1, 2026
  • Part D plans paid (avg)$0.1274per dosage unitgross, before rebates — matched by drug name · 2024
  • Federal contracts pay (FSS)$62.95per package of 24X250MLPfizer Inc. · Jul 1, 2024

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.01$0.02$0.03Mar 2025Aug 2025$0.021
6 price points · per ML · last surveyed Invalid DateSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$140.64
Reported to Texas DSHS · 2026 annual filing · Pfizer Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 1000 CC
$2.181
HCPCS J7030 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2025)

$30,225
8,391 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

28● Elevated risk

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

  • Class I/II recall on same molecule/form in past 12 months+8
  • sterile injectable+10
  • manufacturer plans to discontinue+10

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

1.5%chance of a new FDA shortage posting for sodium chloride (injectable) in the next 90 days

sterile injectable · 13 Class I/II recall(s) in 12 months · OAI inspection at a producing facility (24 months)

For scale: the typical drug’s chance is about 0.1% — this one is 10× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $16.68 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA019465
TE code
AP
Approval date
Jul 15, 1985
Patents / exclusivity
None on file

Shortage history

  • Planned discontinuation — Sodium Chloride 0.9%, Injection, 100 mL ADD-Vantage® Flexible Container (NDC 0409-7101-67)Dec 3, 2025
  • Planned discontinuation — Sodium Chloride 0.9%, Injection, 250 mL ADD-Vantage® Flexible Container (NDC 0409-7101-02)Dec 3, 2025

Recalls (this NDC)

  • Class II · TerminatedApr 7, 2015
    Hospira Inc. — Lack of Sterility Assurance: The product has the potential to leak at the administrative port.
  • Class II · TerminatedMay 4, 2012
    Hospira Inc. — Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags.

Manufacturers of Sodium Chloride (Injection, Solution)

LabelerStrengthFirst seenLast seen
B. Braun Medical Inc.SODIUM CHLORIDE .9 g/100mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCSODIUM CHLORIDE .9 g/100mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCSODIUM CHLORIDE 450 mg/100mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCSODIUM CHLORIDE 9 mg/mLJul 15, 2026Sep 3, 2026
HF Acquisition Co LLC, DBA HealthFirstSODIUM CHLORIDE 9 mg/mLJul 15, 2026Sep 3, 2026
Hospira, Inc.SODIUM CHLORIDE 9 mg/mLJul 15, 2026Sep 3, 2026
ICU Medical Inc.SODIUM CHLORIDE 900 mg/100mLJul 15, 2026Sep 3, 2026
Medical Purchasing Solutions, LLCSODIUM CHLORIDE 9 mg/mLJul 15, 2026Sep 3, 2026
Spectra Medical Deviecs, LLCSODIUM CHLORIDE 9 mg/mLJul 15, 2026Sep 3, 2026
Asclemed USA, Inc.SODIUM CHLORIDE 9 mg/mLJul 15, 2026Sep 2, 2026
B. Braun Medical Inc.SODIUM CHLORIDE 3 g/100mLJul 15, 2026Sep 2, 2026
B. Braun Medical Inc.SODIUM CHLORIDE 9 mg/mLJul 15, 2026Sep 2, 2026
B. Braun Medical Inc.SODIUM CHLORIDE 5 g/100mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationSODIUM CHLORIDE 5 g/100mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationSODIUM CHLORIDE 3 g/100mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationSODIUM CHLORIDE 4.5 g/1000mLJul 15, 2026Sep 2, 2026
Becton Dickinson and CompanySODIUM CHLORIDE .9 g/100mLJul 15, 2026Sep 2, 2026
Becton Dickinson and CompanySODIUM CHLORIDE 450 mg/100mLJul 15, 2026Sep 2, 2026
Becton Dickinson and CompanySODIUM CHLORIDE 9 mg/mLJul 15, 2026Sep 2, 2026
Becton Dickinson And CompanySODIUM CHLORIDE 9 mg/mLJul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCSODIUM CHLORIDE 9 mg/mLJul 15, 2026Sep 2, 2026
Codan Us CorporationSODIUM CHLORIDE 9 g/1000mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCSODIUM CHLORIDE 2250 mg/500mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCSODIUM CHLORIDE 234 mg/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCSODIUM CHLORIDE 3 g/100mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCSODIUM CHLORIDE 225 mg/50mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCSODIUM CHLORIDE 1125 mg/250mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstSODIUM CHLORIDE 900 mg/100mLJul 15, 2026Sep 2, 2026
Hospira, Inc.SODIUM CHLORIDE 900 mg/100mLJul 15, 2026Sep 2, 2026
Laboratorios Grifols SaSODIUM CHLORIDE 9 g/1000mLJul 15, 2026Sep 2, 2026
Medefil, Inc.SODIUM CHLORIDE 9 mg/mLJul 15, 2026Sep 2, 2026
Nextgen Pharmaceuticals LLCSODIUM CHLORIDE 9 g/1000mLJul 15, 2026Sep 2, 2026
ProPharma DistributionSODIUM CHLORIDE 9 g/1000mLJul 15, 2026Sep 2, 2026
SOLA Pharmaceuticals, LLCSODIUM CHLORIDE 9 g/1000mLJul 15, 2026Sep 2, 2026
Sportpharm LLCSODIUM CHLORIDE 9 g/1000mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationSODIUM CHLORIDE 9 g/1000mLJul 15, 2026Aug 31, 2026
ICU Medical Inc.SODIUM CHLORIDE 450 mg/100mLJul 15, 2026Aug 31, 2026
ProPharma DistributionSODIUM CHLORIDE 9 mg/mLJul 15, 2026Aug 31, 2026
Henry Schein, Inc.SODIUM CHLORIDE 9 mg/mLJul 15, 2026Aug 29, 2026
B. Braun Medical Inc.SODIUM CHLORIDE .45 g/100mLJul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Sodium Chloride — NDC 00409-7101-02," retrieved September 3, 2026, https://drugdashboards.com/drug/00409710102.

Free to cite with attribution — see how the data is put together.